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Abstract
Japan Tobacco (JT) is the third largest tobacco company in the world, and China, the world’s largest tobacco
consumer, is one of the most important targets for JT. To provide information for tobacco control, we reviewed
and analyzed JT and its tactics and strategies in the Chinese market mainly by systematic examination of
documents which are made available in the University of California, San Francisco Legacy Tobacco Documents
Library. As a result, JT has had a special interest to expand sales of its cigarettes in the Chinese market.
Introduction
Smoking is a particular challenge for public health
because unlike many other pathogens, this leading cause
of morbidity and mortality worldwide continues to be
actively promoted by large multinational corporations
and governments. Previous writers have described the
activities of the two largest transnational tobacco cor-
porations (TTC) as summarized later. In this paper we
report on the activities of Japan Tobacco (JT), the third
largest TTC and one that, unlike Philip Morris (PM)
and British American Tobacco (BAT), is largely owned
and controlled by the Japanese government. We focus
on JT’s actions aimed at penetrating the Chinese mar-
ket, the largest in the world and heavily dominated by
another government tobacco monopoly, the China
National Tobacco Company (CNTC).
The domestic tobacco business of JT in Japan faces an
increasingly tough environment, as overall demand
declines and competition with other tobacco companies
intensifies. Growth in demand for cigarettes in Japan
b e g a nt os l o wi nt h em i d - 1 9 7 0 sa sar e s u l to fs e v e r a l
factors, including an aging population, growing health
concerns and price increases [1].
The proportion of smokers in Japan has been decreas-
ing over the past 12 years. In 2007, smokers made up
26% of the adult population in Japan [2], down from
35.1% in 1996 and 32.9% in 2000 [3]. According to the
smoking rate survey of Japan conducted in May 2008,
25.7% of Japanese adults smoke [4]. Besides, the 1987
suspension of import tariffs on cigarettes led to rapidly
increased competition in JT’s domestic tobacco market,
which decreased JT’s sales and market share. To combat
the increased competitive pressures, JT has become
more sophisticated and focused in their marketing
efforts, transforming the company from a Japanese
cigarette “manufacturer/distributor” to an International
cigarette “manufacturer/marketer”[5,6]. One of its
tobacco strategies is to “expand internationally into new
markets to provide growth for the tobacco segment.”
Initially, “JT will target larger markets with a good
opportunity, for gaining volume and share (e.g. China,
Korea, Taiwan, Iran, etc.), and will invest in marketing
and spending as required”[5]. Then in 1999, JT pur-
chased the international tobacco operations of US multi-
national R. J. Reynolds and formed JTI, through which it
operates its tobacco business outside of Japan [7].
Among JT’s initial international markets, China is the
largest tobacco producing and consuming country in
the world, with a population of approximately 1.3 billion
[ 8 - 1 0 ] .M e a n w h i l e ,C h i n ais facing a serious public
health problem in active and secondhand smokers.
Smoking is an important risk factor for chronic obstruc-
tive pulmonary disease (COPD), lung cancer and tuber-
culosis [11], which are the second, sixth and eighth
leading causes of death in China, accounting for 2 mil-
lion deaths in 2002 (20.5% of all death in China) [12].
China has over 350 million smokers and about 460 mil-
lion secondhand smokers [8,13], and smoking contribu-
ted to about one million premature deaths annually
[14]. If this pattern of smoking continues, premature
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exceed two million deaths annually by 2020 [15]. In fact,
JT knows “about one in seven non-smokers suffer
r e s p i r a t o r yi l l n e s sb e c a u s eo fe x p o s u r et os m o k ei nt h e
workplace” [16].
O’Sullivan and Chapman [17] and Lee et al [18] stu-
died transnational tobacco company (TTC) industry
documents and described TTC’sa i m sa n dc o n d u c ti n
China, but JT was not mentioned because JTI was
formed in 1999. Zhong and Yano [19] mainly described
British American Tobacco (BAT)’st a c t i c sa n du s eo f
international trade policies to support their corporate
interests. However, no previous papers have analyzed JT
and examined their actions in China, except Assunta’s
doctoral thesis [6].
The objective of this study is to analyze JT and
describe details of JT’s strategies and tactics in China, in
order to provide information for tobacco control in
China and the world.
Methods
For this study, we searched the on-line documents avail-
able from the University of California, San Francisco
(UCSF) Legacy Tobacco Documents Library (LTDL)
http://legacy.library.ucsf.edu and the relevant websites
including Japan Tobacco (JT) http://www.jti.co.jp/JTI/,
Japan Tobacco International (JTI) http://www.jti.com/,
China National Tobacco Company (CNTC) http://www.
tobacco.gov.cn/ and China’s tobacco news website
http://www.tobaccochina.com/.
The keywords we used include “China”, “Japan Tobacco”,
“Chinese market”, “China National Tobacco Company”,
and “State Tobacco Monopoly Administration”.
In LTDL, the keywords were used in the basic and
advanced search and we limited the time between 1998
and 2009. In the homepage of JT, JTI, CNTC and
Tobacco China, we used the keywords in their search
engine. We mainly analyze the documents that were
related to JT itself and JT’s marketing in China. A panel
constitutes one researcher and one expert on tobacco
study. The panel members reviewed the manuscripts
that were searched through from the site mentioned
above in meetings that were conducted twice a month
for a total of 3 months. The Delphi method was used to
select appropriate papers for JT information related to
China [20]. Documents that were illegible, duplicated,
about the tobacco technology and other documents
judged to have little interest to our aim were excluded.
In LTDL, we have reviewed thousands of documents,
but only a few documents have relevance to our study
objective. Thus, compared to PMI and BAT, JT has
released fewer documents and especially the documents
related to China. One of the most important reasons is
that JT was protected by the Japan Tobacco Inc. Law
and Tobacco Business Law of 1984. Even the Japanese
courts do not have the power to subpoena the com-
pany’s internal records, which has made it difficult to
document JT’s strategies [21].
Results
The LTDL search identified 1181 documents, of which
1142 did not meet one or more of the inclusion criteria,
leaving 39 documents for inclusion in the present
review. Besides, there were 12 relevant documents that
were found from the websites of JT, JTI, CNTC and
Tobacco China. As a result, 51 relevant articles were
included for our analysis.
China’s tobacco market
C h i n ai sb yf a rt h ew o r l d ’s largest cigarette market,
accounting for over 30% of total world consumption.
The Chinese cigarette market is nearly three and a half
times the size of the US market and over 12 times the
size of the German market, the largest in Western Eur-
ope [10].
The Chinese population is over 1.3 billion constituting
23% of the world’s population. In addition, in China,
63% of adult males and 4% of females smoke, with 75%
of males starting before the age of 24 [22].
The Chinese cigarette market is dominated by a state-
owned monopoly, the State Tobacco Monopoly Admin-
istration (STMA), which strongly protects the domestic
tobacco industry [23]. The STMA controls all aspects of
the tobacco industry including tobacco growing, proces-
sing, product manufacturing and distribution and also
material and machinery supplies, all of which are oper-
ated through the China National Tobacco Corporation
(CNTC) [10]. CNTC produces over 1.7 trillion cigarettes
annually [24]. Even a small share of such a huge market
would mesmerize any tobacco company.
CNTC and other TTCs
Philip Morris International (PMI) is the leading interna-
tional tobacco company, with products sold in approxi-
mately 160 countries [25]. PMI and CNTC signed an
agreement for the production and marketing of “Marl-
boro” cigarettes, as well as other brands, in China begin-
ning in 1994. The cigarettes have been produced in
existing CNTC factories and have been for both domes-
tic consumption and export. The agreement would not
require any initial capital investment by PMI, but PMI
must introduce technology, training and human
resources expertise to the CNTC’s factories [26]. On
21st December 2005, the CNTC and PMI announced
the establishment of a long-term strategic cooperative
partnership further. Agreements provided for the
licensed manufacture and sale of “Marlboro” cigarettes
in China and establishment of an international equity
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with relevant provisions of the Law of the People’s
Republic of China on Tobacco Monopoly, “Marlboro”,
owned by PMI, will be produced under license at
CNTC’s affiliate factories, and will be distributed by
CNTC’s official distributors nationwide in China. The
international joint venture company to be established by
China National Tobacco Import & Export Group Cor-
poration (CNTIEGC) and PMI, in which each party will
hold 50% of the shares of the company, will be based in
Lausanne, Switzerland. Following its establishment, this
joint venture company will offer consumers a compre-
hensive portfolio of Chinese heritage brands globally,
expand the export of tobacco products and tobacco
materials from China, and explore other business devel-
opment opportunities. The joint venture company will
utilize both CNTC’sa n dP M I ’s extensive sales and dis-
tribution infrastructure, financial resources and manage-
ment experiences to develop business opportunities
worldwide [27].
British American Tobacco (BAT) is the world’s second
largest tobacco group by global market share, with
brand sold in more than 180 markets [28]. BAT China
is one of BAT’s subsidiaries, and existed in China in
1903 already. At present, BAT China is the one-up
international tobacco company in China and set up the
agencies in many major cities. The products of BAT are
imported and distributed by CNTC, and the main pro-
ducts in China are “SE555”, “Kent” and “Hilton” which
are popular with Chinese smokers [29].
BAT entered into China when it was established at
first, and was forced to leave China in 1956. In the
1980s, BAT came back to China again, and cooperated
with Wuhu Cigarette Company to produce cigarettes
named “Dubao” at that time. From then on, BAT coop-
erated with CNTC to manufacture a series of joint ven-
ture brand, including “Coco”, “Huang Guo Trees”, “Le
Fu Door” and so on. In the tobacco leaf field, BAT and
CNTC has been cooperating with each other for almost
10 years [30]. In the middle of the 1990s, BAT began to
“help China’sa g r i c u l t u r e ” by setting up tobacco leaf
base and guiding the tobacco farmers to grow the
tobacco leaf [30]. Besides, BAT China has established
the cooperation plan on the tobacco leaf growth in Yun-
nan and Sichuan province of China [29].
Although CNTC has closer relationship with foreign
tobacco companies year by year, the STMA still keeps
foreign manufactures on tight rein. Importation allot-
ment, marketing and distribution are under direct
supervision of the CNTC. Legal and genuine foreign
cigarettes make up only an estimated 4 percent of Chi-
na’s market. All marketing activities are handled
through the STMA’s China National Tobacco Sales &
Marketing Corporation. Marketing opportunities are,
however, limited. Asla, a spokesperson for Philip Mor-
ris, says, “Print, radio and television advertising are
banned nationwide. Outdoor advertising is permitted
only with prior approval, and is banned in over 70
local jurisdictions.” T og e tt h ew o r do u ti nb i gc i t i e s ,
foreign manufactures often sponsor events and parties
at nightclubs. A common sight on Beijing’sS a nL iT u n
Bar Street, a street of night spots for Beijing’s middle
and upper class, are the “cigarettes girls.” Attractive
young women dressed in Cigarettes Company logos
pass out free samples, lighters and other promotional
items to patrons [31].
The STMA is out to protect its own. Even with WTO
accession, STMA will remain the dominating force of
China’s tobacco industry [31].
Japan Tobacco Company Profile and Its Market Share in
China
JT is a joint stock corporation that was incorporated in
April 1985 under the Commercial Code of Japan, pur-
suant to the JT Law [1]. The history of JT dates back to
1898, when the government formed a monopoly bureau
to operate the exclusive sale of domestic leaf tobacco.
In the early 1900s, the government extended this mono-
poly to all tobacco products in Japan and to the domes-
tic salt business. In 1949, the bureau became the Japan
Tobacco and Salt Public Corporation (JTS), which was
a s s i g n e dt h er o l eo ft h ec o u n t r y ’ss o l ep r o d u c e ra n d
supplier of tobacco and sole purchaser and supplier of
salt products [5].
Between 1981 and 1985, following the demand of US
tobacco industries, US government pressured Japan to
reduce tariff for tobacco import and free access to the
Japanese market [32]. In 1985, the company was chan-
ged from one of governmental sectors to a private com-
pany under the name Japan Tobacco Inc., though 100%
of its share was owned by the government. At the same
time, the Japanese market was fully opened to foreign
tobacco products. In April 1987, all import duties were
removed from foreign cigarettes under the strong pres-
sure from the USA [21] who wanted to ease the trade
imbalance between USA and Japan. This brought down
the price of foreign cigarettes and increased the market
share of imported cigarettes dramatically [5]. JT was
semi-privatized in the same year, and two thirds of the
company was owned by Japan’s Ministry of Finance
[21]. Beginning in 1988, JT began focusing efforts into
diversification with the establishment of JT Agris Cor-
poration in agribusiness, JT Engineering Inc. in systems
engineering and Lifix Inc. to increase participation in
the pharmaceutical industry [5]. According to JT’sm a n -
agement vision developed in 1995, JT proposed to
concentrate in three strategic areas: (1) foreign business;
(2) medical business and (3) food [33].
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company that develops diversified, value-creating busi-
nesses” [1]. JT’s domestic tobacco market was in the
charge of JT’s headquarters, and the domestic market
share is 65.1% in the fiscal year of 2009 [1]. In the
domestic tobacco market, total demand for cigarettes
has continued to decline and increases in the tobacco
excise tax that took effect in July 2003 and July 2006
had an additional impact on the market. Meanwhile, as
tobacco-related regulations are being strengthened in
various ways, market share competition with foreign
brands is intensifying. JT hopes to overcome these diffi-
culties, in order to ensure that the domestic tobacco
business continues to serve as the JT Group’sc o r e
source of profits [1].
T h ew o r l dm a r k e ts h a r eo fJ T Ii s1 0 . 6 %a n dt h ep r o -
ducts of JTI were sold in over 120 countries in the fiscal
year of 2008 [1]. In 2007, Gallaher Group Plc was
acquired by JT, which leads to sharp increase of interna-
tional sales (Figure 1). Now, JTI’s business covers almost
all over the world, including North & Central Europe
(UK, Ireland, Sweden, and Austria), Commonwealth of
Independent States, namely CIS+ (Russia, Kazakhstan,
Ukraine and Romania), South & West Europe (such as
Spain, France, Italy and Greece) and Rest of the world
(Taiwan, Malaysia, Turkey, Canada etc.). Based on the
Global Flagship Brands (GFB) containing Winston,
Camel, Mild Seven, Benson & Hedges, Silk Cut, LD,
Sobranie and Glamour, international tobacco business
has been continuing to be the profit growth engine of
the JT group [1].
JT has been concentrating its sales in China for a long
time because “the Chinese Market is extremely large,
and is estimated to be worth an annual 1.7 trillion
dollars. The market is expected to continue to grow and
JT plans to continue strengthening its sales strategies in
China” [34]. Between 1989 and 1992, JT’s cigarettes
accounted for 1.1%-1.5% among the all tobacco products
imported from foreign countries by China [5]. In 1995,
China’s imports from Japan (which represent mainly
JT’s Mild Seven brand) were about 0.43 billion pieces,
which accounted for about 0.025% in Chinese cigarette
markets then [10]. In 2001, the market share of JT in
China was about 0.1% [35]. However, fortunately total
tobacco sales in the mainland of China have not
increased as of 2009 [1].
Advantages of JT
J Th a ss o m eu n i q u ea d v a n t a g e sr e l a t i v et oo t h e rT T C s ,
such as limited litigation history, no transparency about
its activities because it was not included in the Master
Settlement Agreement and government support.
Little litigation
Compared to PMI and BAT, JT has little litigation.
There are only 24 litigation cases related to JT by the
end of May 2008, while, there are 137 and 3329 aiming
to PMI and BAT respectively by the end of December
2007 [36]. JT and its subsidiaries have never lost a case
or paid any money to settle a case out of court [1].
Not in the Master Settlement Agreement
In 1998, the availability of tobacco industry documents
increased exponentially as a result of the settlement of a
suit by the state of Minnesota and Blue Cross/Blue
Shield against the major tobacco companies. As part of
the Minnesota settlement, Attorney General Humphrey
required that the defendants release millions of pages of
internal documents. These documents are stored in
depositories in Minnesota and Guildford, England. The
Master Settlement Agreement between the attorneys
general of 46 states and B&W/BAT, Lorillard, Philip
Morris, RJ Reynolds, the Council for Tobacco Research,
and the Tobacco Institute required that the documents
be made available on the Internet and be updated until
2010 [37]. JT is not in this agreement.
Supported by the Japanese government
In 1985, JT was established under the Japan Tobacco,
Inc. Law ("the JT Law”) for the purpose of developing
businesses related to the manufacture, sale, and impor-
tation of tobacco products. In advance, the Tobacco
Business Law was enacted in August 1984 for the pur-
pose of achieving sound growth for Japan’s tobacco
industry, securing stable government revenues, and con-
tributing to the healthy expansion of the Japanese econ-
omy [1]. Because of this law, Japan can not declare
reduction of smoking in the below mentioned “Health
Figure 1 T h eI n c r e a s eo fJ T ’s International Sales after Taxes.
Source: reference [55].
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Framework Convention on Tobacco Control (FCTC).
Japan ratified the FCTC in June 2004, being among the
first 20 countries to do so [38]. Among the negotiations
for the FCTC, Japan’s participation presented particular
interest of tobacco industry. At the first two Intergovern-
mental Negotiating Body sessions (INB), the Japanese
delegation consisted mainly of representatives of the
Ministry of Health, Labor and Welfare (MHLW) and had
no representation from the Ministry of Finance (MOF).
However, the Japanese delegation consisted of 20 mem-
bers at the 6th Intergovernmental Negotiating Body ses-
sion, by which time there were as many representatives
from the MOF as there were from the MHLW [39]. The
MOF has direct and indirect influence over JT, including
its overall policies. The participation of the ministry may
be seen as representing tobacco industry interest [40].
Similarly, Japan’s Ministry of Agriculture, Forestry and
Fisheries has historically supported tobacco interests
because of Japan’s sizable tobacco agriculture crop and
the strong political constituency of tobacco farmers [41].
At last, the Japanese delegation successfully weakened
t h eF C T Cb ya r g u i n gf o re x t e n s i v eo p t i o n a ll a n g u a g e
[39], which is good for the Japanese tobacco industry–JT.
In Japan, there is a 10 year nation-wide health pro-
gram—"Health Japan 21st”, which was approved by the
cabinet. In the Health Japan 21st, there are many
numerical goals including regular exercise, suicide
reduction and prevention of heavy drinking, but a target
for smoking cessation was not included. Before 2000,
Japan’s MHLW once stated a goal of halving the preva-
lence of smoking by 2010 [42]. However, after strong
opposition by tobacco industry, Ministry of Agriculture,
and the MOF, even the reduction of adult smoking was
not mentioned. Only remained were prohibition of
under age smoking, support smoking cessation for those
who want to quit smoking, and dissemination of knowl-
edge for health hazard caused by tobacco.
Besides, many of the company executives of JT were
retired officers of MOF. For the first 15 years after JT’s
privatization in 1985, the top position of JT has been
regarded as the next job for the top officers of MOF. All
of the three former CEOs of JT had been either ex-Dep-
uty Minister of MOF or ex-Director General of the
National Tax Agency [43].
The cooperation between JT and China
JT started to cooperate with China in the 1980s. In
order to compensate for the reduction in the volume of
sales of cigarettes on the home market and for export,
the Japan Tobacco International Corporation (JATICO,
later JTI) was established in April 1984. In the middle of
1984 JTS and CNTC reached an agreement on the
arrangement for an exchange of technology. Afterwards,
JT opened an office in Beijing of China in February
1985. Meanwhile China had imported cigarettes from
Japan at a value of five million dollars while Japan had
purchased from China over 1000 tones of leaf tobacco
and fairly large quantities of Salt. The main JT’sp r o -
ducts in China at that time are Mild Seven, Seven Stars,
Hope, Peace, Castes, Hi-Lite [44]. JT’s important inter-
national market contains Taiwan, Korea, and mainland
of China at the earlier time [44].
Besides, JT has been cooperating with CNTC to produce
“Youqi” and “Huaying”,a n ds o m e“Camel” cigarettes are
produced in Yanji Cigarettes Factory in Jilin [45]. In fact,
Yanji Cigarettes Factory in Jilin cooperated with RJ Rey-
nolds at first. RJ Reynolds had concluded a licensing
arrangement with Yanji Cigarettes Factory for the local
production of “Camel”, which is being announced in
December 1998. In March 1999, JT took control of RJ
Reynolds’ international operations, and consequently since
then, JT cooperates with Yanji Cigarettes Factory rather
than RJ Reynolds [10].
JT’s former President Masaru Mizuno once said in an
interview “JT will continue looking for alliance with over-
seas companies so that it can survive a drop in domestic
demand for cigarettes. China could be a big market in
the future, though it depends on the way China joins the
WTO. We have jointly developed a new brand of cigar-
ettes with a Chinese company, and soon that company
will start manufacturing their products” [46]. The com-
pany Mizuno referred is Shanghai Gaoyang International
Tobacco Co. JT began to make cigarettes in China from
2000 for marketing its own brands. JT hoped to tap the
Chinese market and planned to turn out 400 million
cigarettes a year in Shanghai, marketing them under its
top-selling brands such as Mild Seven and Mild Seven
Light. This was its first local production in China. After
that JT looked into cooperating with the Shanghai firm
in low-tar, low-nicotine production technology and pro-
duct development for the Chinese market [47].
In addition, JT also developed the market for Shanghai
Tobacco Company in Japan through its own channels.
In November 2003, “Zhong Hua”, “Double Happiness”
and “Golden Deer” of Shanghai Tobacco Corporation
entered Japan’s market by Unitobacco which is JT’s sub-
sidiary in charge of distributing imported cigarettes [45].
Technically speaking, Shanghai Tobacco Corporation
entering into Japan means the loss of JT’sd o m e s t i c
market share. What JT did is in order to keep a good
relationship with CNTC and increase their market share
in China in the future [45].
JT’s marketing activities in China
Before China joined the WTO, JT already knew “our
sales may not expand rapidly in China in the near future
because of high tariffs and distribution network
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size and recent economic progress.” Thus, JT has main-
tained 11 offices in China before 2000, which are pre-
paring for brisk business in the future [48]. In addition,
the CEO of JT said “JT will not lose Chinese market by
no means once China opens its market.”“ We must pay
special attention to Chinese market, especially its inter-
national commercial conditions. It is not an easy thing
to enter into China....... But I think our products will
have some perspective in Chinese market according to
our sales situation in Korea and Taiwan.” [45]
In January 2003, JT established the China Division
especially for Chinese market under its Tobacco Head-
quarters. The division centralizes two functions: the for-
mation of key relationships in the Chinese market
through technical support and other activities, which
had previously been handled by the JT parent company,
and the marketing of tobacco products, which had been
handled by subsidiary JTI. The aim of this reorganiza-
tion is to strengthen its medium- and long-term activ-
ities in the Chinese market in view of China’s entry into
the WTO [49].
In recent years, JT has set up clubs named “Mild
Seven Times” in some big Chinese cities, the service of
which provide has no relevance with JT’s cigarettes
brand on the surface. Though in reality, “Mild Seven
Times” has the function of popularizing JT’sb r a n d
among Chinese smokers, so JT’s cigarettes are quietly
advertised in Chinese market in a “peaceful and friendly”
way. JT also sponsored the “Mild Seven Outdoor Quest”
i no r d e rt od oa d v e r t i s e m e n tf o ri t sb r a n di nC h i n a ,
which is a four-day stage adventure race, covering
approximately 300 kilometers and containing 7 events:
mountain biking, kayaking, in-line skating, adventure
skills, paddling and running. “Mild Seven Outdoor
Quest” has great effect on the targeted consumers, espe-
cially the young people [45]. JT is only allowed to spon-
sor these events in China and Malaysia because of
stringent laws, so lack of local regulation in China and
Malaysia provide an opportunity for JT to do this. Mild
Seven Outdoor Quest was famous for triathletes, it was
held in China from 1997 to 2001 and in Malaysia from
2002 to 2004, the race was finished in 2005 [50].
Discussions
JT’s ambition in China and the issues of public health
Although it is not publicly recognized, JT is very active in
China today. Even if China has begun to restrict tobacco
advertising, promotion and sponsorship on radio, televi-
sion, printed media and the internet [51], JT still adopts
other strategies to advertise its products in China. For
example, it has established “Mild Seven Times” in some
cities, sponsors “Mild Seven Outdoor Quest”,a n dp a r t i -
cularly “China Division” was established in JT specified
for Chinese market. All of these actions revealed JT’s
ambition in China. The fact that Chinese business was
transferred from JTI to China Division in JT headquarter
demonstrates that JT has paid more and special attention
to Chinese market. In JT’s Annual Report 2004, “Net
sales from the domestic tobacco business increased
despite the drop in the sales volume of tobacco products
in Japan.” Because “the impact of decline in sales volume
was offset by the inclusion of net sales in China, Hong
Kong and Macau as part of the domestic tobacco busi-
ness starting in the fiscal year ended March 31, 2004”
[52]. So it’s obviously that JT has treated Chinese tobacco
market as its domestic market, which discloses JT’s ambi-
tion in China.
In addition, cigarette smoking causes an enormous
economic burden in China through a huge number of
preventable diseases, health care costs, premature
deaths, and productivity losses. The total economic
costs had grown from $3.3 billion in 1989 to $5.0 billion
in 2000 [53]. Since the health effects of smoking on
morbidity and mortality are cumulative, China will bear
a much heavier economic burden from cigarette smok-
ing in the future if the current trends in smoking beha-
vior continue [54]. Because more than half of the stock
of JT is held by the Japanese government, the Japanese
people may be forced to bear the huge burden of litiga-
tion and claim for compensation in future. So far, JT
suffers from burden of litigations very little but the
situation may change at any moment coming from any
place due to its worldwide and rapidly expanding
business.
Form the angle of all over the world, Tobacco has
already killed 100 million people in the 20th century,
and 5.4 million deaths per year currently result from
tobacco use. In the absence of urgent action, more than
8 million tobacco-related deaths are predicted for every
year beginning in 2030, and approximately 1 billion
tobacco-related deaths are predicted to occur during the
21st century [54]. We must intensify attention to the
role of tobacco companies as vectors of smoking and
emphasize responsibilities of the Japanese government
for tobacco control.
Limitations
We admit that the search for documents is incomplete.
Firstly, the valuable documents released by JT are so
few. Secondly, we only mainly choose the documents
which are between 1999 and 2009. Thirdly, the number
of documents in LTDL and other related website is
continually expanding as time goes on, so we undoubt-
edly do not analyze the documents after our given
period.
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JT has adopted lots of novel and effective strategies in
China which demonstrates that JT has great ambition in
the Chinese market. JT’s activities are threat to humans’
health and the movement of tobacco control. We must
focus more on drawing attention to the responsibility of
tobacco companies for tobacco control.
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